Transcatheter pulmonary valve implantation using the edwards SAPIEN™ transcatheter heart valve

Abstract

The SAPIEN THV can be used successfully in the treatment of patients with right ventricle to pulmonary artery homograft failure. The valve is durable to at least 3.5 years without stent fracture or regurgitation. Clinical trials are underway to assess the long-term safety and efficacy of this valve.